C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2695415
The present invention provides a biomarker that is predictive for the response to treatment with an EGFR inhibitor in cancer patients
La présente invention porte sur un biomarqueur qui est prédictif de la réponse au traitement par un inhibiteur d'EGFR chez des patients atteints de cancer.
Delmar Paul
Klughammer Barbara
Lutz Verena
Mcloughlin Patricia
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Egfr inhibitor treatment marker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Egfr inhibitor treatment marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Egfr inhibitor treatment marker will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1439139